3
Peripheral pain mechanisms in chronic widespread pain

https://doi.org/10.1016/j.berh.2010.01.010Get rights and content

Clinical symptoms of chronic widespread pain (CWP) conditions like fibromyalgia (FM), include pain, stiffness, subjective weakness, and muscle fatigue. Muscle pain in CWP is usually described as fluctuating and often associated with local or generalised tenderness (hyperalgesia and/or allodynia). This tenderness related to muscle pain depends on increased peripheral and/or central nervous system responsiveness to peripheral stimuli, which can be either noxious (hyperalgesia) or non-noxious (allodynia). For example, patients with muscle hyperalgesia will rate painful muscle stimuli higher than normal controls, whereas patients with allodynia may perceive light touch as painful, something that a ‘normal’ individual will never describe as painful. The pathogenesis of such peripheral and/or central nervous system changes in CWP is unclear, but peripheral soft tissue changes have been implicated.

Indirect evidence from interventions that attenuate tonic peripheral nociceptive impulses in patients with CWP syndromes like FM suggest that overall FM pain is dependent on peripheral input. More importantly, allodynia and hyperalgesia can be improved or abolished by removal of peripheral impulse input. Another potential mechanism for CWP pain is central disinhibition. However, this pain mechanism also depends on tonic impulse input, even if only inadequately inhibited. Thus, a promising approach to understanding CWP is to determine whether abnormal activity of receptors in deep tissues is fundamental to the development and maintenance of this chronic pain disorder.

Conclusions

Most CWP patients present with focal tissue abnormalities including myofascial trigger points, ligamentous trigger points or osteoarthritis of the joints and spine. While not predictive for the development of CWP, these changes nevertheless represent important pain generators that may initiate or perpetuate chronic pain. Local chemical mediators, including lactic acid, adenosine triphosphate (ATP) and cytokines, seem to play an important role in sensitising deep tissue nociceptors of CWP patients. Thus, the combination of peripheral impulse input and increased central pain sensitivity may be responsible for widespread chronic pain disorders including FM.

Section snippets

Chronic widespread pain

The prevalence of chronic pain in the general population is high, seems to increase with age [1], [2], and is usually assessed by cross-sectional studies utilising screening questionnaires sent to a random sample of subjects [2]. These questionnaires collect information about demographic data, diagnosis, current pain, pain during the previous month, recurring pain, pain duration, location, frequency, intensity, pain at rest or during movement, occupational status, working hours per week, use of

FM syndrome

FM patients encountered in clinical practice are not necessarily representative of patients in the general population because these patients differ in pain severity and lifetime psychiatric diagnoses from FM patients found in the community [8], [9]. Similar findings have been documented for CWP [10]. FM is a chronic pain syndrome, that is defined by widespread pain for more than 3 months and the presence of more than 10 out of 18 tender points [11]. Additionally, almost all FM patients complain

Pathogenesis of CWP and FM

Similar to CWP, FM pain appears to depend on impulse input from deep tissues, particularly muscles. In genetically susceptible individuals, such tonic impulse input results in peripheral sensitisation as well as neuroplastic changes of the central nervous system (CNS), termed ‘central sensitisation’. During central sensitisation, a cascade of transcriptional and translational events leads to heightened sensitivity (hyperalgesia and/or allodynia) of second- and higher-order neurons and expansion

Role of muscle impulse input for CWP

Although there are no detectable nociceptors in muscle fibres [22], [23], [24] muscle stimuli can elicit pain. Nociceptive afferent fibres including A-delta and C-fibres can be found in muscles as dense innervations of vascular structures [25], *[26], [27]. Whereas chronic degenerative muscle disorders are not painful, inflammatory myopathies can result in sensitisation of pain receptors that may elicit pain. Hypoxia in combination with muscle activity as well as energy depletion can also cause

Role of myofascial trigger points for overall pain

Local pain of CWP and FM patients is often related to the presence of myofascial trigger points (MTPs) which can be classified as either active or latent. Whereas active MTPs are characterised by spontaneous pain, latent MTPs are clinically silent but usually have all the other clinical characteristics of active MTPs, including taut bands and twitch response [41], [42], [43]. Active MTPs are associated with local and referred pain and a characteristic twitch response after manual or needle

Effects of local pain on generalised pain sensitivity

It is well known that small areas of local pain can have enhancing effects on overall pain sensitivity. This effect, however, depends on several factors including the duration of pain. In contrast to short-lasting dental pains which do not enhance pain sensitivity of distal sites like the arms [50], chronic pain from myofascial temporomandibular disease can profoundly increase pain sensitivity of remote areas [51]. Generalised hyperalgesia has also been described in patients with local pain

Muscle metabolites and pain

A likely source of nociceptive input accounting for FM pain is muscle tissue. Several types of muscle abnormalities have been reported in FM patients including the appearance of ragged red fibres, inflammatory infiltrates and moth-eaten fibres. Possible mechanisms for such muscle changes may include repetitive muscle microtrauma, which could contribute to the postexertional pain, MTP and other painful symptoms experienced by these patients. In addition, prolonged muscle tension and ischaemia

Role of abnormal muscle microcirculation

The blood flow of muscles, particularly the trapezius, seems to be reduced in FM [66]. Muscle microcirculation can be measured by Doppler ultrasound [66], [67], xenon-133 clearance [68] or oxygen multipoint electrodes on the muscle surface of FM patients [69]. The trapezius and brachioradialis muscles have been most frequently studied. Tissue oxygen pressures are reported to be abnormal in FM patients compared to normal controls [70]. These results suggest abnormal capillary microcirculation,

Mechanisms of pain in CWP

Pain in CWP is consistently felt in deep tissues and is related to sensitisation of peripheral and CNS pain pathways. Neurotrophins such as nerve growth factor (NGF) and tachykinins such as SP are elevated in the cerebrospinal fluid (CSF) of FM patients [79]. NGF and SP not only enhance the sensitivity of nociceptors but also are associated with inflammatory regulation [80]. Specifically, administration of recombinant human NGF to pain-free volunteers can result in mild-to-moderate back pain

Role of peripheral and central pain mechanisms

Increasing evidence points towards multiple initiating factors for hyperalgesia in FM, in particular psychological and physical stress, including traumatic injuries [86], [87]. Once hyperalgesia has been established little continuous tonic impulse input seems to be required for its maintenance. Several studies have demonstrated abnormalities of pain processing in patients with FM, such as alterations of N-methyl-d-aspartate receptors or monoaminergic modulation in the spinal cord [18], [39],

Summary

Although muscle biopsy studies do not conclusively show specific abnormalities for CWP syndromes such as FM, the presence of moth-eaten fibres, ragged red fibres and type II fibre atrophy indicates that muscles are likely involved in the pathogenesis of CWP [71], [103], [104], [105], [106]. Abnormalities of muscle perfusion in FM may result in lowered pH during mild-to-moderate muscle load sufficient for activation of muscle nociceptors. Such changes have been reported in the local milieu of

Acknowledgements

Supported by NIH grant AR-053541.

Reference (107)

  • R. Bennett

    Myofascial pain syndromes and their evaluation

    Best Practice & Research Clinical Rheumatology

    (2007)
  • D.G. Simons

    Review of enigmatic MTrPs as a common cause of enigmatic musculoskeletal pain and dysfunction

    Journal of Electromyography and Kinesiology

    (2004)
  • H.Y. Ge et al.

    The predetermined sites of examination for tender points in fibromyalgia syndrome are frequently associated with myofascial trigger points

    Journal of Pain

    (2010)
  • G. Affaitati et al.

    A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds

    Clinical Therapeutics

    (2009)
  • W. Maixner et al.

    Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain

    Pain

    (1995)
  • P. Bajaj et al.

    Antenatal women with or without pelvic pain can be characterized by generalized or segmental hypoalgesia in late pregnancy

    Journal of Pain

    (2002)
  • T. Ushida et al.

    Changes in dorsal horn neuronal responses in an experimental wrist contracture model

    Journal of Orthopaedic Science

    (2001)
  • U. Hoheisel et al.

    Functional reorganization in the rat dorsal horn during an experimental myositis

    Pain

    (1994)
  • R. Staud et al.

    Spatial summation of heat pain within and across dermatomes in fibromyalgia patients and pain-free subjects

    Pain

    (2004)
  • N. Julien et al.

    Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition

    Pain

    (2005)
  • G.N. Verne et al.

    Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients

    Pain

    (2003)
  • K.A. Sluka et al.

    Chronic hyperalgesia induced by repeated acid injections in muscle is abolished by the loss of ASIC3, but not ASIC1

    Pain

    (2003)
  • A. Elvin et al.

    Decreased muscle blood flow in fibromyalgia patients during standardised muscle exercise: a contrast media enhanced colour doppler study

    European Journal of Pain

    (2006)
  • S.E. Larsson et al.

    Chronic pain after soft-tissue injury of the cervical spine: trapezius muscle blood flow and electromyography at static loads and fatigue

    Pain

    (1994)
  • A. Bengtsson et al.

    Regional sympathetic blockade in primary fibromyalgia

    Pain

    (1988)
  • C.J. Vierck et al.

    The effect of maximal exercise on temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome

    Journal of Pain

    (2001)
  • G.R. Lewin et al.

    Nerve growth factor and nociception

    Trends in Neurosciences

    (1993)
  • K.Y. Fu et al.

    Long-lasting inflammation and long-term hyperalgesia after subcutaneous formalin injection into the rat hindpaw

    Journal of Pain

    (2001)
  • L. Neumann et al.

    Outcome of posttraumatic fibromyalgia: a 3-year follow-up of 78 cases of cervical spine injuries

    Seminars in Arthritis and Rheumatism

    (2003)
  • T. Graven-Nielsen et al.

    Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients

    Pain

    (2000)
  • B. Berglund et al.

    Quantitative and qualitative perceptual analysis of cold dysesthesia and hyperalgesia in fibromyalgia

    Pain

    (2002)
  • M. Granot et al.

    Simultaneous recording of late and ultra-late pain evoked potentials in fibromyalgia

    Clinical Neurophysiology

    (2001)
  • J. Lorenz et al.

    Middle and long latency somatosensory evoked potentials after painful laser stimulation in patients with fibromyalgia syndrome

    Electroencephalography and Clinical Neurophysiology

    (1996)
  • M. Meeus et al.

    Diffuse noxious inhibitory control is delayed in chronic fatigue syndrome: an experimental study

    Pain

    (2008)
  • E. Kosek et al.

    Lack of pressure pain modulation by heterotopic noxious conditioning stimulation in patients with painful osteoarthritis before, but not following, surgical pain relief

    Pain

    (2000)
  • R. Staud et al.

    Maintenance of windup of second pain requires less frequent stimulation in fibromyalgia patients compared to normal controls

    Pain

    (2004)
  • L. Lindell et al.

    Prevalence of fibromyalgia and chronic widespread pain

    Scandinavian Journal of Primary Health Care

    (2000)
  • B. Gerdle et al.

    Prevalence of current and chronic pain and their influences upon work and healthcare-seeking: a population study

    Journal of Rheumatology

    (2004)
  • S. Bergman et al.

    Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study

    Journal of Rheumatology

    (2001)
  • P.R. Mobily et al.

    An epidemiologic analysis of pain in the elderly. The Iowa 65 + health study

    Journal of Aging Health

    (1994)
  • P. Croft et al.

    The prevalence of chronic widespread pain in the general population

    Journal of Rheumatology

    (1993)
  • L. Coster et al.

    Chronic widespread musculoskeletal pain - a comparison of those who meet criteria for fibromyalgia and those who do not

    European Journal of Pain

    (2007)
  • F. Wolfe et al.

    The prevalence and characteristics of fibromyalgia in the general population

    Arthritis and Rheumatism

    (1995)
  • L.A. Aaron et al.

    Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness

    Arthritis and Rheumatism

    (1996)
  • S. Benjamin et al.

    The association between chronic widespread pain and mental disorder – a population-based study

    Arthritis and Rheumatism

    (2000)
  • F. Wolfe et al.

    The American college of rheumatology 1990 criteria for the classification of Fibromyalgia. Report of the multicenter criteria committee

    Arthritis and Rheumatism

    (1990)
  • F. Wolfe et al.

    The American college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity

    Arthritis Care and Research

    (2010)
  • P. Sarzi-Puttini et al.

    Increased neural sympathetic activation in fibromyalgia syndrome

    Annals of the New York Academy of Sciences

    (2006)
  • L.J. Crofford

    The relationship of fibromyalgia to neuropathic pain syndromes

    Journal of Rheumatology Supplement

    (2005)
  • R.D. Gerwin

    A review of myofascial pain and fibromyalgia - factors that promote their persistence

    Acupuncture in Medicine

    (2005)
  • Cited by (113)

    • Cutaneous pain in disorders affecting peripheral nerves

      2021, Neuroscience Letters
      Citation Excerpt :

      The focus of this review is on how cutaneous nociception (pain perceived from the skin) is altered following diseases that affect peripheral nerves. Whereas many types of common acute and chronic pain are associated with deeper target tissues such as muscle, bone, fascia and visceral organs, the mechanisms and processes underlying deep tissue pain are reviewed elsewhere [3,5–10]. Importantly, the spinal cord, brainstem, cortex and descending pain faciliatory and inhibitory pathways are extensively involved in central sensitization [11] and altered circuit signaling in painful peripheral neuropathies.

    View all citing articles on Scopus
    View full text